EA201691920A1 - Новые конденсированные соединения имидазобензотиазола - Google Patents

Новые конденсированные соединения имидазобензотиазола

Info

Publication number
EA201691920A1
EA201691920A1 EA201691920A EA201691920A EA201691920A1 EA 201691920 A1 EA201691920 A1 EA 201691920A1 EA 201691920 A EA201691920 A EA 201691920A EA 201691920 A EA201691920 A EA 201691920A EA 201691920 A1 EA201691920 A1 EA 201691920A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
imdiabobenzoiazole
new condensed
new
pharmaceutically acceptable
Prior art date
Application number
EA201691920A
Other languages
English (en)
Other versions
EA029745B9 (ru
EA029745B1 (ru
Inventor
Пундлик Шинде
Санджай Сривастава
Давиндар Тули
Дипак Рай
Прашант Гдж
Шайлеш Дешпанде
Рамешчандра Гупта
Виджай Чхаутхайвале
Чхайтанья Дутт
Original Assignee
Торрент Фармасьютикалз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Торрент Фармасьютикалз Лимитед filed Critical Торрент Фармасьютикалз Лимитед
Publication of EA201691920A1 publication Critical patent/EA201691920A1/ru
Publication of EA029745B1 publication Critical patent/EA029745B1/ru
Publication of EA029745B9 publication Critical patent/EA029745B9/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

Настоящее изобретение относится к новым конденсированным производным имидазобензотиазола, их фармацевтически приемлемым солям и их изомерам, стереоизомерам, атропизомерам, конформерам, таутомерам, полиморфам, гидратам, сольватам и N-оксиду. Настоящее изобретение охватывает также фармацевтически приемлемые композиции указанных соединений и способ получения новых соединений. Кроме того, изобретение относится к применению вышеупомянутых соединений для получения лекарственного препарата для применения в качестве фармацевтических препаратов.
EA201691920A 2014-03-27 2015-03-24 Конденсированные соединения имидазобензотиазола EA029745B9 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1089MU2014 2014-03-27
PCT/IB2015/052124 WO2015145336A1 (en) 2014-03-27 2015-03-24 Novel fused imidazobenzothiazole compounds

Publications (3)

Publication Number Publication Date
EA201691920A1 true EA201691920A1 (ru) 2017-01-30
EA029745B1 EA029745B1 (ru) 2018-05-31
EA029745B9 EA029745B9 (ru) 2018-08-31

Family

ID=54194050

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201691920A EA029745B9 (ru) 2014-03-27 2015-03-24 Конденсированные соединения имидазобензотиазола

Country Status (29)

Country Link
US (2) US9908898B2 (ru)
EP (1) EP3122755B1 (ru)
JP (1) JP6480949B2 (ru)
KR (1) KR102339610B1 (ru)
CN (1) CN106414458B (ru)
AR (1) AR099867A1 (ru)
AU (1) AU2015237840B2 (ru)
CA (1) CA2943098C (ru)
CY (1) CY1121147T1 (ru)
DK (1) DK3122755T3 (ru)
EA (1) EA029745B9 (ru)
ES (1) ES2707099T3 (ru)
HR (1) HRP20190121T1 (ru)
HU (1) HUE042493T2 (ru)
IL (1) IL247955B (ru)
LT (1) LT3122755T (ru)
MX (1) MX368985B (ru)
MY (1) MY193041A (ru)
PH (1) PH12016501903A1 (ru)
PL (1) PL3122755T3 (ru)
PT (1) PT3122755T (ru)
RS (1) RS58324B1 (ru)
SG (1) SG11201607793RA (ru)
SI (1) SI3122755T1 (ru)
TR (1) TR201900735T4 (ru)
TW (1) TWI648282B (ru)
UA (1) UA121469C2 (ru)
WO (1) WO2015145336A1 (ru)
ZA (1) ZA201606598B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015011445A (es) 2013-03-15 2016-04-20 Global Blood Therapeutics Inc Compuestos y usos de estos para la modulacion de la hemoglobina.
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
TWI648282B (zh) * 2014-03-27 2019-01-21 印度商托仁特生技有限公司 新熔合咪唑苯并噻唑化合物
DE102016209204A1 (de) 2016-05-27 2017-11-30 Robert Bosch Gmbh Vorrichtung zur Regelung mindestens eines Fluidstroms in einem Fahrzeug
KR102630959B1 (ko) * 2016-10-31 2024-01-29 엘지디스플레이 주식회사 유기 화합물과 이를 이용한 발광다이오드 및 유기발광다이오드 표시장치
CN106727538A (zh) * 2017-02-20 2017-05-31 潘连香 一种治疗2型糖尿病的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724566D0 (en) 1987-10-20 1987-11-25 Roussel Lab Ltd Chemical compounds
GB8908845D0 (en) 1989-04-19 1989-06-07 Roussel Lab Ltd Chemical compounds
US6191124B1 (en) 1994-04-29 2001-02-20 Pharmacia & Upjohn Company Methanol derivatives for treatment of retroviral infections especially HIV infections
WO2002014321A1 (en) * 2000-08-11 2002-02-21 The Regents Of The University Of California Use of stat-6 inhibitors as therapeutic agents
US7601846B2 (en) * 2001-06-26 2009-10-13 The Regents Of The University Of California Compounds having activity as inhibitors of apoptosis
WO2004048368A2 (en) * 2002-11-25 2004-06-10 Pharmacia Corporation Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors
GB0320244D0 (en) * 2003-05-06 2003-10-01 Aventis Pharma Inc Pyrazoles as inhibitors of tumour necrosis factor
JP2009526037A (ja) * 2006-02-09 2009-07-16 ファイザー・リミテッド トリアゾロピリジン化合物
TWI648282B (zh) * 2014-03-27 2019-01-21 印度商托仁特生技有限公司 新熔合咪唑苯并噻唑化合物

Also Published As

Publication number Publication date
AU2015237840A1 (en) 2016-09-29
PT3122755T (pt) 2019-01-30
EA029745B9 (ru) 2018-08-31
IL247955A0 (en) 2016-11-30
EP3122755A1 (en) 2017-02-01
WO2015145336A1 (en) 2015-10-01
US10227361B2 (en) 2019-03-12
JP6480949B2 (ja) 2019-03-13
CA2943098A1 (en) 2015-10-01
CA2943098C (en) 2022-07-05
CN106414458A (zh) 2017-02-15
ZA201606598B (en) 2017-11-29
PH12016501903B1 (en) 2017-01-09
CY1121147T1 (el) 2020-05-29
CN106414458B (zh) 2019-10-29
KR102339610B1 (ko) 2021-12-14
EP3122755B1 (en) 2018-11-07
US20180127437A1 (en) 2018-05-10
HUE042493T2 (hu) 2019-07-29
SG11201607793RA (en) 2016-10-28
UA121469C2 (uk) 2020-06-10
AR099867A1 (es) 2016-08-24
JP2017513825A (ja) 2017-06-01
LT3122755T (lt) 2019-02-11
DK3122755T3 (en) 2019-02-18
AU2015237840B2 (en) 2019-06-20
HRP20190121T1 (hr) 2019-03-08
TWI648282B (zh) 2019-01-21
MY193041A (en) 2022-09-23
KR20160129089A (ko) 2016-11-08
MX2016012535A (es) 2017-05-04
SI3122755T1 (sl) 2019-02-28
NZ724342A (en) 2021-02-26
IL247955B (en) 2021-02-28
PL3122755T3 (pl) 2019-05-31
TR201900735T4 (tr) 2019-02-21
MX368985B (es) 2019-10-23
US20170107233A1 (en) 2017-04-20
PH12016501903A1 (en) 2017-01-09
EA029745B1 (ru) 2018-05-31
RS58324B1 (sr) 2019-03-29
ES2707099T3 (es) 2019-04-02
TW201613941A (en) 2016-04-16
US9908898B2 (en) 2018-03-06

Similar Documents

Publication Publication Date Title
PH12017500166A1 (en) 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors
EA033544B1 (ru) Производные пиридона в качестве ингибиторов киназы, реаранжированной во время трансфекции (ret)
MX2017010477A (es) Compuestos triciclicos y usos de los mismos en medicina.
EA201790389A1 (ru) Пирролопиримидиновые соединения, используемые в качестве агониста tlr7
EA201791256A1 (ru) Производные хиназолина, применяемые для лечения вич
MX2016009403A (es) Compuestos heterociclicos.
EA201891063A1 (ru) Производные дигидроимидазопиразинона, применимые в лечении рака
EA201591195A1 (ru) Новые хинолоновые производные
EA201691920A1 (ru) Новые конденсированные соединения имидазобензотиазола
MX2017002896A (es) Uso del agente de refuerzo del receptor del acido gamma-aminobutirico tipo a (gabaa) en la preparacion de un sedante y medicamento anestesico.
CY1124251T1 (el) Παραγωγα καρβοξαμιδιου
PH12017501830A1 (en) Novel pyridinium compounds
EA201692298A1 (ru) Производные карбоксамидов
PH12016502243A1 (en) Pharmaceutical compositions for treating infectious diseases
EA201700356A1 (ru) Новые циклопропанбензофуранилпиридопиразиндионы
EA201791480A1 (ru) Новые производные бензимидазола в качестве антигистаминных агентов
MX2017013099A (es) Metodos para el tratamiento de trastornos inflamatorios.
EA201270556A1 (ru) Конденсированные тиазоло и оксазолопиримидиноны
PH12017500323B1 (en) P38 map kinase inhibiting indanyl urea compounds
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
MX2017002627A (es) Derivados de polieteres macrociclicos de n-aril-2-amino-4-aril-pir imidina como inhibidores de ftl3 y jak.
MX2018015990A (es) Compuestos terapeuticos.
MX2017013103A (es) Metodos para el tratamiento de trastornos cardiovasculares.
MX2017002747A (es) Derivados de polieteres macrociclicos de n-aril-triciclopirimidin- 2-amino como inhibidores de ftl3 y jak.

Legal Events

Date Code Title Description
TH4A Publication of the corrected specification to eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM